Literature DB >> 23392718

Over-expression of LRIG3 suppresses growth and invasion of bladder cancer cells.

Yong Qi1, Lei Chang1, Heng Li1, Gan Yu1, Wei Xiao1, Ding Xia1, Wei Guan1, Yang Yang1, Bin Lang2, Kang-Li Deng1, Wei-Min Yao1, Zhang-Qun Ye1, Qian-Yuan Zhuang3.   

Abstract

The purpose of this study was to investigate the impact of leucine-rich repeats and immunoglobulin-like domains 3 (LRIG3) on the biological features of bladder cancer cell lines. The plasmids of over-expressed LRIG3 and the blank plasmid serving as control were transfected into the bladder cancer cell lines, T24, EJ and BIU-87, and the expression levels of LRIG3 mRNA and protein were detected by using real-time PCR and Western blotting. The changes in the cell cycle and apoptosis were examined by using flow cytometry. The invasive ability was measured by Transwell assay, and CCK-8 assays were used to measure the proliferation of cells. As compared with the control group, the LRIG3 mRNA and protein expression levels in LRIG3 cDNA-transfected group were raised significantly (P<0.05). The average number of cells with up-regulated LRIG3 passing through the inserted filter was decreased significantly as compared with the control group (P<0.05). Up-regulation of LRIG3 also could inhibit proliferation and induce apoptosis of T24, EJ and BIU-87 cells. Except BIU-87, the T24 and EJ cells transfected with LIRG3 cDNA were arrested in G(0)/G(1) phase compared to the control group (P<0.05). In conclusion, the over-expression of LRIG3 could influence the cell cycle and invasion, inhibit proliferation and induce apoptosis in the three bladder cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392718     DOI: 10.1007/s11596-013-1081-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  18 in total

1.  LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy.

Authors:  David L Shattuck; Jamie K Miller; Melanie Laederich; Melanie Funes; Heidi Petersen; Kermit L Carraway; Colleen Sweeney
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

2.  Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1.

Authors:  Fan Li; Zhang-Qun Ye; Dong-Sheng Guo; Wei-Min Yang
Journal:  Oncol Rep       Date:  2011-05-10       Impact factor: 3.906

3.  Cloning, characterization, and expression of human LIG1.

Authors:  J Nilsson; C Vallbo; D Guo; I Golovleva; B Hallberg; R Henriksson; H Hedman
Journal:  Biochem Biophys Res Commun       Date:  2001-06-29       Impact factor: 3.575

Review 4.  The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy.

Authors:  M W Pedersen; M Meltorn; L Damstrup; H S Poulsen
Journal:  Ann Oncol       Date:  2001-06       Impact factor: 32.976

5.  Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.

Authors:  G Reifenberger; K Ichimura; J Reifenberger; A G Elkahloun; P S Meltzer; V P Collins
Journal:  Cancer Res       Date:  1996-11-15       Impact factor: 12.701

6.  Is LRIG1 a tumour suppressor gene at chromosome 3p14.3?

Authors:  Håkan Hedman; Jonas Nilsson; Dongsheng Guo; Roger Henriksson
Journal:  Acta Oncol       Date:  2002       Impact factor: 4.089

7.  Characterization and tissue-specific expression of human LRIG2.

Authors:  Camilla Holmlund; Jonas Nilsson; Dongsheng Guo; Anna Starefeldt; Irina Golovleva; Roger Henriksson; Håkan Hedman
Journal:  Gene       Date:  2004-05-12       Impact factor: 3.688

8.  The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.

Authors:  Melanie B Laederich; Melanie Funes-Duran; Lily Yen; Ellen Ingalla; Xiuli Wu; Kermit L Carraway; Colleen Sweeney
Journal:  J Biol Chem       Date:  2004-09-01       Impact factor: 5.157

9.  Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts.

Authors:  Hitoshi Kurokawa; Ken-ichi Katsube; Katarzyna A Podyma; Minoru Ikuta; Hachirou Iseki; Motowo Nakajima; Takumi Akashi; Ken Omura; Minoru Takagi; Masaki Yanagishita
Journal:  Cancer Sci       Date:  2003-03       Impact factor: 6.716

10.  Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity.

Authors:  Fei Ye; Qinglei Gao; Tongjiang Xu; Liang Zeng; Yibo Ou; Feng Mao; Heping Wang; Yue He; Baofeng Wang; Zhengming Yang; Dongsheng Guo; Ting Lei
Journal:  J Neurooncol       Date:  2009-03-20       Impact factor: 4.130

View more
  2 in total

1.  Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer.

Authors:  Rosário Pinto-Leite; Isabel Carreira; Joana Melo; Susana Isabel Ferreira; Ilda Ribeiro; Jaqueline Ferreira; Marco Filipe; Carina Bernardo; Regina Arantes-Rodrigues; Paula Oliveira; Lúcio Santos
Journal:  Tumour Biol       Date:  2014-01-24

2.  Positional plasticity in regenerating Amybstoma mexicanum limbs is associated with cell proliferation and pathways of cellular differentiation.

Authors:  Catherine D McCusker; Antony Athippozhy; Carlos Diaz-Castillo; Charless Fowlkes; David M Gardiner; S Randal Voss
Journal:  BMC Dev Biol       Date:  2015-11-23       Impact factor: 1.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.